Outlook on the RNA Based Therapeutic Global Market to 2030 - Multifactorial Disease Targeting Presents Opportunities
April 28, 2022 06:43 ET
|
Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "RNA Based Therapeutic Market by Disease Type, Application and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been...
Global RNAi Therapeutics Market Insights & Forecast Report 2022-2026: Rising Utilization in Oncology Pharmaceuticals & Progress in Collaborations and Associated Deals in RNAi Therapeutics
April 21, 2022 04:43 ET
|
Research and Markets
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19...
Global RNAi Therapeutics Market Report 2022-2026: Analysis by Molecule Type - Small Interference RNA (siRNA), and Micro RNA (miRNA)
April 08, 2022 06:23 ET
|
Research and Markets
Dublin, April 08, 2022 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market: Analysis By Molecule Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2026"...
Oncotelic Presenting at MedInvest Pharmaceutical and Biotechnology Investor Conference
February 24, 2022 08:47 ET
|
Oncotelic Therapeutics, Inc.
OT-101 is Oncotelic’s RNA Therapeutic Against TGF-βOT-101 has completed over six clinical trials against solid tumors with good efficacyOT-101 is currently undergoing a phase 1b trial in combination...
mRNA Therapeutics and Vaccine Market Report 2022: Key Opinion Leaders Profiles and Recent Activity Snapshots
February 24, 2022 04:28 ET
|
Research and Markets
Dublin, Feb. 24, 2022 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics and Vaccines: Key Opinion Leaders" report has been added to ResearchAndMarkets.com's offering. Over the last two decades, medical...
Global RNA Stabilization & Delivery Technology Advances Market Report 2021: LNP- and Bioconjugation-based Nonviral RNA Delivery Technologies to Gain Momentum in the Next 3 Years
February 15, 2022 05:43 ET
|
Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Technological Advances in RNA Stabilization & Delivery" report has been added to ResearchAndMarkets.com's offering. RNA therapeutics is a rapidly...
Global Nucleic Acid Based Gene Therapy Market Research Report 2021 Featuring Wave Life Sciences, Imugene, Caperna, Phylogica, Benitec, EGEN, BioMedica, Transgene and Copernicus Therapeutics
February 07, 2022 04:08 ET
|
Research and Markets
Dublin, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The "Nucleic Acid Based Gene Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
Global microRNA Markets Report 2021-2028 - High Investments in miRNA R&D Initiatives for Development of New Diagnostic Tests & Therapeutics
September 15, 2021 07:13 ET
|
Research and Markets
Dublin, Sept. 15, 2021 (GLOBE NEWSWIRE) -- The "Global microRNA Market Size, Share & Trends Analysis Report 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global...
2021 Insights on the RNA Therapeutics Global Market - Stability of mRNA Vaccines and RNA Therapeutics at Ambient Temperature Presents Opportunities
July 15, 2021 05:23 ET
|
Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "RNA Therapeutics: Global Technology Growth Opportunities, 2021" report has been added to ResearchAndMarkets.com's offering. RNA therapeutics is a...
Global Antisense & RNAi Therapeutics Market Report 2021: Market is Expected to Reach $1.79 Billion in 2025 at a CAGR of 11% - Forecast to 2030
June 17, 2021 07:03 ET
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...